|
Indian Pediatr 2011;48: 805-806 |
|
Lipoprotein Lipase Deficiency in an Infant |
Sheela Nampoothiri, *Natasha Radhakrishnan,
‡Andrea Schwentek and Michael
Marcus Hoffmann
From the Departments of Pediatric Genetics and
*Ophthalmology, Amrita Institute of Medical Sciences and Research Center,
Cochin, Kerala; and ‡University Medical Center, Division of Clinical
Chemistry, Hugstetter Str. 55, D-79106 Freiburg i. Br, Germany.
Correspondence to: Sheela Nampoothiri, Consultant,
Department of Pediatric Genetics, Amrita Institute of Medical Sciences &
Research Center, Aims Ponekkara PO, Cochin 682041, Kerala, India.
Email: [email protected]
Received: May 19, 2010;
Initial review: May 19, 2010;
Accepted: July 9, 2010.
|
Patients with isolated hypertriglyceridemia usually present with
recurrent abdominal pain, pancreatitis, eruptive xanthomas, lipemia
retinalis and hepatosplenomegaly. We describe the diagnosis and
treatment of an infant with severe hypertriglyceridemia. The child was
found to be heterozygous for two novel mutations in the lipoprotein
lipase gene.
Key words: Hypertriglyceridemia, Lipoprotein
lipase deficiency, Lipemia retinalis, Medium chain triglyceride oil,
Mutation analysis.
|
L ipoprotein lipase (LPL) is the rate-limiting
enzyme for the hydrolysis of triglycerides in chylomicrons and
very-low-density lipoproteins (VLDL). LPL is active as a homodimer;
for full enzymatic activity, the presence of apolipoprotein (apo)
CII is required as a cofactor. The LPL gene is located on chromosome
8p22 and as a result of mutations in this gene, the enzyme is either
not produced or becomes catalytically inactive [1].
Genetic deficiency of LPL or its cofactor apo CII
causes type I hyperlipoproteinemia syndrome, which is characterized
by the presence of chylomicrons (CM) in fasting plasma and a marked
increase in plasma triglyceride levels. The estimated prevalence for
Western countries is 1 in 1:10 6
[1].
Case Report
A 38-day old male baby was referred for
evaluation in genetic clinic following the observation of lipemic
(milky) serum during the evaluation for fever. Baby was the first
child born to non consanguineous parents with a birthweight of 3.5
kg and was exclusively breastfed. He had hepatomegaly of 4 cm below
right costal margin. Fundus examination revealed lipemia retinalis.
There were no eruptive xanthomas. Laboratory studies showed serum
triglycerides of 8874 mg% and cholesterol 659 mg%. Lipoprotein
electrophoresis showed very high levels of pre
b
lipoproteins and presence of chylomicronemia, thyroid function tests
were normal, and SGOT was 480 IU/L, SGPT 120 IU/L and alkaline
phosphate was 1150 1U/L. Total serum protein was 11.3 g/dL and
albumin was 5.1 g/dL and globulin was 8.1 g/dL. Ultrasound study of
abdomen was normal. Hemoglobin was 19.9 g/dL, whereas the RBC count
was only 3.07 m/uL. In presence of extremely elevated
triglyceridemia with moderate elevation of cholesterol, lipemic
serum and lipemia retinalis, possibility of familial LPL deficiency
or apolipoprotein C II deficiency were considered. LPL mass
measurement could not be performed due to non availability of this
test in India.
To analyze the underlying molecular defect,
complete apoC II gene, the promoter, and all 10 exons of the LPL
gene were sequenced. The apo CII gene showed no change, whereas two
novel mutations were detected in the LPL gene: +3insT in intron 1,
which was transmitted together with the Ser447Stop variant by the
mother. The possibility that the insertion in intron 1 disturbs the
splicing of the LPL mRNA is very high because in the consensus
sequence for splicing the nucleotide T at position +3 has the lowest
probability [2]. The second mutation is a C/T exchange in exon 5
leading to the change of proline 214 into serine and it was
transmitted by the father. Exon 5 codes for a portion of a
hydrophobic pocket in which the proposed catalytic triad is located.
It is very likely that the exchange of proline by the hydrophilic
serine will lead to an inactive enzyme. This is supported by the
very strong conservation of the protein sequence of this area in
mammals.
Baby was started on a fat restricted diet from
40th day of life. There was a dramatic decrement in the serum
triglycerides (TG) and cholesterol levels after 2 weeks of
introduction of completely skimmed milk and medium chain
triglycerides (MCT) oil. 10% of the caloric need was provided by MCT
oil. Baby was also given multivitamin drops and vitamin E
supplementation. Four weeks after starting this modified diet there
was significant improvement in biochemical parameters.
40 days after initiation of therapy, the fundus
evaluation showed near normal level vessels and retina. Semisolids
were introduced at 4 th
month and he was entirely switched to skimmed milk. Baby was
monitored once monthly and now the baby is 24 months old and has
normal growth and development and is on normal diet, skimmed milk,
MCT oil and multivitamins.
Discussion
Familial hyperchylomicronemia syndrome is an
autosomal recessive disorder which results from LPL deficiency,
apolipoprotein CII deficiency or familial inhibitors to LPL.
Patients with this disorder have increased risk of pancreatitis and
they present with hepatosplenomegaly, lipemia retinalis and eruptive
xanthomas. Recurrent pancreatitis ultimately leads to pancreatic
insufficiency, which is the major threat of this disease [3]. About
25% of patients with familial chylomicronemia manifest complications
before the age of one year and majority develop before 10 years and
the most common symptoms include severe recurrent colicky abdominal
pain, failure to thrive and acute pancreatitis [4]. TG levels above
2000 mg/dL predisposes to pancreatitis. High TG values lead to false
low value for sodium, hemoglobin and bilirubin [5].
Detection of LPL mass and activity in the plasma
of affected patients after heparin administration is one way to
search for the underlying defect of LPL deficiency but these assays
are not freely available and therefore the genetic analysis is
becoming the most readily applied diagnostic method [6].
The parents, heterozygote for one LPL mutation,
did not show any abnormalities in their lipids. Heterozygous
carriers of LPL deficiency have moderate elevation of TG and
decrease of HDL and they are predisposed to development of ischemic
heart disease [5].
The mainstay of management is strict adherence to
fat restriction which should be continued throughout life. MCT is
recommended for patients with chylomicronemia as it is directly
absorbed into the portal circulation [5]. Addition of coconut oil
for cooking helps to provide MCT. The ultimate aim is to maintain TG
values < 2000mg/dL so that it decreases the risk of pancreatitis.
Lipid lowering drugs are not very effective in
familial LPL deficiency and gene therapy is in its infancy [5,7].
Once the chylomicronemia is cleared, the patient is advised to
consume a non-fat rice based diet, fruits with small portions of
fish and meat. Life style management includes physical activity
which also helps to decrease TG [8]. Diet modification should start
as early as possible and therefore detailed evaluations of those
infants are strongly recommended when lipemic serum is detected
during routine evaluation.
Contributors: SN: diagnosed and managed the
condition in the index case and drafted the article. She will act as
the guarantor of the manuscript. NR: ophthalmologic evaluation of
the child and parents. AS: genetic analysis. MMH: interpreted the
genetic data and helped in manuscript writing.
Funding: None.
Competing interests: None stated.
References
1. Rahalkar AR, Giffen F, Har B, Ho J, Morrison
KM, Hill J, et al. Novel LPL mutations associated with
lipoprotein lipase deficiency: two case reports and a literature
review. Can J Physiol Pharmacol. 2009;87:151-60.
2. Cartegni L, Chew SL, Krainer AR. Listening to
silence and understanding nonsense: exonic mutations that affect
splicing. Nat Rev Genet. 2002;3:285-98.
3. Santamarina-Fojo S. The familial
chylomicronemia syndrome. Endocrinol Metab Clin North Am.
1998;27:551-67.
4. Pouwels ED, Blom DJ, Firth JC, Henderson HE,
Marais AD. Severe hypertriglyceridaemia as a result of familial
chylomicronaemia: the Cape Town experience. S Afr Med J.
2008;98:105-8.
5. Kavazarakis E, Stabouli S, Gourgiotis D,
Roumeliotou K, Traeger- Synodinos J, Bossios A, et al. Severe
hypertriglyceridaemia in a Greek infant: a clinical, biochemical and
genetic study. Eur J Pediatr. 2004;163:462-6.
6. Hoffmann MM, Jacob S, Luft D, Schmulling RM,
Rett K, Marz W, et al. Type I hyperlipoproteinemia due to a
novel loss of function mutation of lipoprotein lipase, Cys(239) >Trp,
associated with recurrent severe pancreatitis. J Clin Endocrinol
Metab. 2000;85:4795-8.
7. Stroes ES, Nierman MC, Meulenberg JJ, Franssen
R, Twisk J, Henny CP, et al. Intramuscular administration of
AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein
lipase-deficient patients. Arterioscler Thromb Vasc Biol.
2008;28:2303-4.
8. Leaf DA. Chylomicronemia and the
chylomicronemia syndrome: a practical approach to management. Am J
Med. 2008;121:10-2.
|
|
|
|